Activity of superoxide dismutase, catalase and glutathione peroxidase in rats exposed to chlorpyrifos and erofloxacin

• Autorzy: Barski D. , Spodniewska A. , Zasadowski A.
• Języki publikacji: EN

Abstrakty

EN

The aim of the study was to investigate the influence of administration of chlorpyrifos and/or enrofloxacin on the activity of chosen antioxidative enzymes i.e.: superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GPx) in erythrocytes of rats. Chlorpyrifos was administered by stomach tube during 28 days at a dose of 3 mg/kg bw (0.02 LD50), and enrofloxacin was administered by stomach tube at a dose of 5 mg/kg bw during 3 subsequent days. It was stated that administration of enrofloxacin at applied dose did not cause any major changes in the activity of investigated antioxidative enzymes. The four-week exposure of rats to chlorpyrifos caused noticeable decrease in SOD and CAT activity in erythrocytes of rats at the beginning of the experiment (up to 24th hour) in comparison with the control group. The activity of GPx during all periods of the experiment was increased. In the group of animals in which both chlorpyrifos and enrofloxacin were applied, the profile of changes in activity of examined enzymes was similar to that one, which was observed after administration of chlorpyrifos exclusively, what may indicate lack of co-action between compounds used in the experiment.

• Wydawca: -
• Czasopismo: Polish Journal of Veterinary Sciences
• Rocznik: 2011
• Tom: 14
• Numer: 4
• Opis fizyczny: p.523-529,ref.

Twórcy

autor

Barski D.

• Department Pharmacology and Toxicology, Faculty of Veterinary Medicine, University of Warmia and Mazury in Olsztyn,Oczapowskiego 14, 10-719 Olsztyn, Poland

autor

Spodniewska A.

autor

Zasadowski A.

Bibliografia

• Aebi H (1984) Catalase in vitro. Methods Enzymol 105: 121-126.
• Albesa I, Becerra MC, Battán PC, Páez PL (2004) Oxidative stress involved in the antibacterial action of different antibiotics. Biochem Biophys Res Commun 317: 605-609.
• Altinordulu S, Eraslan G (2009) Effects of some quinolone antibiotics on malondialdehyde levels and catalase activity in chicks. Food Chem Toxicol 47: 2821-2823.
• Amitai G, Moorad D, Adani R, Doctor BP (1998) Inhibition of acetylcholinesterase and butyrylcholinesterase by chlorpyrifos-oxon. Biochem Pharmacol 56: 293-299.
• Anadón A, Martínez-Larrañaga MR, Díaz MJ, Fernández-Cruz ML, Martínez MA, Frejo MT, Martínez M, Iturbe J, Tafur M (1999) Pharmacokinetic variables and tissue residues of enrofloxacin and ciprofloxacin in healthy pigs. Am J Vet Res 60: 1377-1382.
• Anderson TD, Zhu KY (2004) Synergistic and antagonistic effects of atrazine on the toxicity of organophosphorodithioate and organophosphorothioate insecticides to Chironomus tentans (Diptera: Chironomidae). Pestic Biochem Phys 80: 54-64.
• Barski D, Zasadowski A (2008) Activity of superoxide dismutase and catalase in erythrocytes and malondialdehyde concentration in the liver of rats exposed to Bi 58 Nowy and pyrantel. Bull Vet Inst Pulawy 52: 299-303.
• Becerra MC, Sarmiento M, Páez PL, Argüello G, Albesa I (2004) Light effect and reactive oxygen species in the action of ciprofloxacin on Staphylococcus aureus. J Photochem Photobiol B 76: 13-18.
• Benzer F, Kılıç A, Yılmaz S, Erişir M, Timurkaan N, Ertaş HB (2009) Influence of enrofloxacin administration on oxidative stress and antioxidant enzyme activities of experimentally infected broilers with Salmonella enterica serovar enteritidis. E-Journal of New World Sciences Academy, Veterinary Sciences, 4: 24-33.
• Bimazubute M, Cambier C, Baert K, Vanbelle S, Chiap P, Albert A, Delporte JP, Gustin P (2010) Penetration of enrofloxacin into the nasal secretions and relationship between nasal secretions and plasma enrofloxacin concentrations after intramuscular administration in healthy pigs. J Vet Pharmacol Ther 33: 183-188.
• Boothe DM, Boeckh A, Simpson RB, Dubose K (2006) Comparison of pharmacodynamic and pharmacokinetic indices of efficacy for 5 fluoroquinolones toward pathogens of dogs and cats. J Vet Intern Med 20: 1297-1306.
• Carreras I, Castellari M, García Regueiro JA, Guerrero L, Esteve-García E, Sárraga C (2004) Influence of enrofloxacin administration and alpha-tocopheryl acetate supplemented diets on oxidative stability of broiler tissues. Poult Sci 83: 796-802.
• Cetin N, Cetin E, Eraslan G, Bilgili A (2007) Chlorpyrifos induces cardiac dysfunction in rabbits. Res Vet Sci 82: 405-408.
• Cochran RC, Kishiyama J, Aldous C, Carr WC Jr, Pfeifer KF (1995) Chlorpyrifos: hazard assessment based on a review of the effects of short-term and long-term exposure in animals and humans. Food Chem Toxicol 33: 165-172.
• De Lucas JJ, Navarro JL, Rubio S, Vignolo PE, Asis VC, González F, Rodríguez C (2008) Pharmacokinetic behaviour of enrofloxacin in greater rheas following a single-dose intramuscular administration. Vet J 175: 136-138.
• Dhalla NS, Temsah RM, Netticadan T (2000) Role of oxidative stress in cardiovascular diseases. J Hypertens 18: 655-673.
• Durak D, Uzun FG, Kalender S, Ogutcu A, Uzunhisarcikli M, Kalender Y (2009) Malathion-induced oxidative stress in human erythrocytes and the protective effect of vitamins C and E in vitro. Environ Toxicol 24: 235-242.
• Elmas M, Yazar E, Uney K, Er Karabacak A (2006) Influence of Escherichia coli endotoxin-induced endotoxaemia on the pharmacokinetics of enrofloxacin after intravenous administration in rabbits. J Vet Med A Physiol Pathol Clin Med 53: 410-414.
• Foxenberg RJ, McGarrigle BP, Knaak JB, Kostyniak PJ, Olson JR (2007) Human hepatic cytochrome P450-specific metabolism of parathion and chlorpyrifos. Drug Metab Dispos 35: 189-193.
• Goel A, Dani V, Dhawan DK (2005) Protective effects of zinc on lipid peroxidation, antioxidant enzymes and hepatic histoarchitecture in chlorpyrifos-induced toxicity. Chem Biol Interact 156: 131-140.
• Gotfried MH, Grossman RF (2010) Short-course fluoroquinolones in acute exacerbations of chronic bronchitis. Expert Rev Respir Med 4: 661-672.
• Grobbel M, Lübke-Becker A, Wieler LH, Froyman R, Friederichs S, Filios S (2007) Comparative quantification of the in vitro activity of veterinary fluoroquinolones. Vet Microbiol 124: 73-81.
• Hillier A, Alcorn JR, Cole LK, Kowalski JJ (2006) Pyoderma caused by Pseudomonas aeruginosa infection in dogs: 20 cases. Vet Dermatol 17: 432-439.
• Ihrke PJ, Papich MG, DeManuelle TC (1999) The use of fluoroquinolones in veterinary dermatology. Vet Dermatol 10: 193-204.
• Karademir Catalgol B, Ozden S, Alpertunga B (2007) Effects of trichlorfon on malondialdehyde and antioxidant system in human erythrocytes Toxicol in Vitro 21: 1538-1544.
• Kulikowska-Karpińska E, Moniuszko-Jakoniuk J (2004) The antioxidative barrier in the organism. Pol J Environ Stud 13: 5-13.
• Lemus R, Abdelghani A (2000) Chlorpyrifos: an unwelcome pesticide in our homes. Rev Environ Health 15: 421-433.
• Lukaszewicz-Hussain A (2008) Subchronic intoxication with chlorfenvinphos, an organophosphate insecticide, affects rat brain antioxidative enzymes and glutathione level Food Chem Toxicol 46: 82-86.
• Mansour SA, Mossa AH (2009) Lipid peroxidation and oxidative stress in rat erythrocytes induced by chlorpyrifos and the protective effect of zinc. Pestic Biochem Physiol 93: 34-39.
• Maroni M, Colosio C, Ferioli A, Fait A (2000) Biological monitoring of pesticide exposure: a review. Toxicology 143: 1-118.
• Martínez M, McDermott P, Walker R (2006) Pharmacology of the fluoroquinolones: a perspective for the use in domestic animals. Vet J 172: 10-28.
• Muscarella DE, Keown JF, Bloom SE (1984) Evaluation of the genotoxic and embryotoxic potential of chlorpyrifos and its metabolites in vivo and in vitro. Environ Mutagen 6: 13-23.
• Mutch E, Williams FM (2006) Diazinon, chlorpyrifos and parathion are metabolised by multiple cytochromes P450 in human liver. Toxicology 224: 22-32.
• Pitchumoni SS, Doraiswamy PM (1998) Current status of antioxidant therapy for Alzheimer's Disease. J Am Geriatr Soc 46: 1566-1572.
• Riddle C, Lemons CL, Papich MG, Altier C (2000) Evaluation of ciprofloxacin as a representative of veterinary fluoroquinolones in susceptibility testing. J Clin Microbiol 38: 1636-1637.
• Sams C, Cocker J, Lennard MS (2004) Biotransformation of chlorpyrifos and diazinon by human liver microsomes and recombinant human cytochrome P450s (CYP). Xenobiotica 34: 861-873.
• Shenouda J, Green P, Sultatos L (2009) An evaluation of the inhibition of human butyrylcholinesterase and acetylcholinesterase by the organophosphate chlorpyrifos oxon. Toxicol Appl Pharmacol 241: 135-142.
• Sivapiriya V, Jayanthisakthisekaran, Venkatraman S (2006) Effects of dimethoate (O, O-dimethyl S-methyl carbamoyl methyl phosphorodithioate) and ethanol in antioxidant status of liver and kidney of experimental mice. Pestic Biochem Phys 85: 115-121.
• Sultatos LG, Murphy SD (1983) Hepatic microsomal detoxification of the organophosphates paraoxon and chlorpyrifos oxon in the mouse. Drug Metab Dispos 11: 232-238.
• Traş B, Maden M, Baş AL, Elmas M, Yazar E, Civelek T (2001) Investigation of biochemical and haematological side-effects of enrofloxacin in dogs. J Vet Med A Physiol Pathol Clin Med 48: 59-63.
• Tu HT, Silvestre F, Bernard A, Douny C, Phuong NT, Tao CT, Maghuin-Rogister G, Kestemont P (2008) Oxidative stress response of black tiger shrimp (Penaeus monodon) to enrofloxacin and to culture system. Aquaculture 285: 244-248.
• Uzun FG, Demir F, Kalender S, Bas H, Kalender Y (2010) Protective effect of catechin and quercetin on chlorpyrifos-induced lung toxicity in male rats. Food Chem Toxicol 48: 1714-1720.
• Vancutsem PM, Babish JG, Schwark WS (1990) The fluoroquinolone antimicrobials: structure, antimicrobial activity, pharmacokinetics, clinical use in domestic animals and toxicity. Cornell Vet 80: 173-186.
• Verma R, Mehta A, Srivastava N (2007) In vivo chlorpyrifos induced oxidative stress: Attenuation by antioxidant vitamins. Pestic Biochem Phys 88: 191-196.
• Wang YC, Chan JP, Yeh KS, Chang CC, Hsuan SL, Hsieh YM, Chang YC, Lai TC, Lin WH, Chen TH (2010) Molecular characterization of enrofloxacin resistant Actinobacillus pleuropneumoniae isolates. Vet Microbiol 142: 309-312.
• Wiuff C, Lykkesfeldt J, Aarestrup FM, Svendsen O (2002) Distribution of enrofloxacin in intestinal tissue and contents of healthy pigs after oral and intramuscular administrations. J Vet Pharmacol Ther 25: 335-342.
• Yazar E, Tras B (2001) Effects of fluoroquinolone antibiotics on hepatic superoxide dismutase and glutathione peroxidase activities in healthy and experimentally induced peritonitis mice. Revue Med Vet 152: 235-238.
• Zhang LL, Zhang JR, Guo K, Ji H, Zhang Y, Jiang SX (2011) Effects of fluoroquinolones on CYP4501A and 3A in male broilers. Res Vet Sci 90: 99-105.